What's Happening?
Alamance Community College (ACC) in Graham, North Carolina, has been awarded a federal grant of $474,878 from the National Science Foundation’s (NSF) Advanced Technological Education (ATE) program. This funding will support the launch of 'BioQuest,' an initiative
designed to prepare students for careers in biopharma quality. ACC is one of only two institutions in North Carolina to receive NSF-ATE funding for biotechnology this year. The BioQuest program will establish a new Associate in Applied Science (AAS) degree in Biopharma Quality, with the first courses scheduled to begin in Fall 2027. This new degree aims to address the significant demand for quality control and quality assurance technicians in North Carolina’s Piedmont region, who are responsible for ensuring products meet company standards and U.S. Food and Drug Administration requirements. The curriculum will include six new courses developed in response to skill gaps identified by ACC’s Business Industry Leadership Team, an advisory committee of local industry partners. These courses will cover quality control testing, regulatory compliance, process validation, documentation, and data integrity, integrating data analytics, automation, and artificial intelligence.
Why It's Important?
This NSF grant is crucial for bolstering the biotechnology workforce in North Carolina and potentially nationwide. The biopharma industry is rapidly expanding, and there is a strong, unmet demand for skilled technicians in quality control and assurance. By providing specialized training through the new AAS degree, ACC will directly contribute to filling these critical workforce gaps, ensuring that pharmaceutical and biotechnology products meet stringent quality and regulatory standards. This initiative will enhance hands-on training opportunities, strengthen industry partnerships, and provide students with access to cutting-edge technologies and experiences relevant to today’s biotechnology sector. The program's focus on industry-aligned training, including real-world equipment and embedded microcredential badges, will produce graduates who are immediately ready for employment, thereby supporting economic growth and innovation in the biopharma sector. Furthermore, the flexible hybrid evening format and short course sessions are designed to accommodate working adults and career changers, making these valuable educational opportunities accessible to a broader demographic and fostering career advancement.
What's Next?
Over the next three years, ACC will implement the BioQuest program, with the first courses for the new AAS degree in Biopharma Quality commencing in Fall 2027. The project team will develop six new courses, incorporating input from industry partners to ensure the curriculum addresses current skill gaps. In the project’s second year, ACC plans to actively recruit working adults and under-skilled workers from Alamance County, as well as high school students enrolled in local biomedical courses. In its final year, ACC intends to share the developed curriculum, materials, and teaching methods online and through train-the-trainer workshops for faculty at other North Carolina biotechnology departments, with the potential for national dissemination. Industry Expansion Solutions at NC State University will provide support for evaluating the project’s effectiveness and impact. The long-term goal is to establish a sustainable model for biopharma quality education that can be replicated across the country, continuously supplying the industry with a highly skilled workforce.
Beyond the Headlines
The BioQuest initiative represents a significant step towards addressing the broader challenge of workforce development in specialized technical fields. By focusing on biopharma quality, ACC is not only responding to immediate industry needs but also contributing to the overall integrity and safety of pharmaceutical products. The integration of data analytics, automation, and artificial intelligence into the curriculum reflects the evolving technological landscape of the biopharma sector, preparing students for future advancements. The program's emphasis on creating accessible pathways for working adults and high school students highlights a commitment to inclusive education and economic mobility. This model could serve as a blueprint for other community colleges looking to align their educational offerings with high-demand industries, fostering a more skilled and adaptable national workforce. The sharing of curriculum and teaching methods with other institutions also promotes a collaborative approach to education, potentially elevating the standard of biopharma education across the U.S. and strengthening the nation's position in the global biotechnology market.
